A Phase 2 trial evaluating TMP-301's efficacy and safety in patients with alcohol use disorder. A drug-drug interaction (DDI) study assessing TMP-301 in individuals using cocaine.

Windows 11 Despite the fact that the TMP 2.0 and secure boot requirements have been known for a while now, many users are still confused as to why Windows 11 is requiring what has been, to date ...

Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a potent, selective and orally available mGluR5 ...

Tempero Bio, Inc., a clinical-stage biopharmaceutical company developing transformative treatments for substance use disorders, today announced the closing of a $70 million Series B financing. The ...